Drug Profile
Levetiracetam - Aprecia Pharmaceuticals
Alternative Names: CNS disorder therapeutic - Aprecia Pharmaceuticals; Product 1 - Aprecia Pharmaceuticals; SpritamLatest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator Aprecia Pharmaceuticals
- Class Acetamides; Antidementias; Antiepileptic drugs; Neuroprotectants; Nootropics; Pyrrolidinones; Small molecules
- Mechanism of Action SV2A protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Seizures